1. EachPod

Oncology Times - OncTimes Talk - Podcast

Oncology Times - OncTimes Talk

 Oncology Times

OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.

News Medicine Science & Medicine Health
Update frequency
every 4 days
Average duration
13 minutes
Episodes
199
Years Active
2009 - 2025
Share to:
Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!

Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!

00:06:57  |   Tue 13 Oct 2009
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

00:07:19  |   Tue 13 Oct 2009
Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality

Swedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular Mortality

00:04:20  |   Tue 13 Oct 2009
The Disappointment of the NSABP C-08 Trial

The Disappointment of the NSABP C-08 Trial

00:09:05  |   Tue 13 Oct 2009
Research Policy Expert: Overhaul Cancer Research Priorities Globally Now!

Research Policy Expert: Overhaul Cancer Research Priorities Globally Now!

00:09:39  |   Tue 13 Oct 2009
Advanced Biliary Cancer Controlled with Cetuximab Added to GEMOX

Advanced Biliary Cancer Controlled with Cetuximab Added to GEMOX

00:02:18  |   Wed 02 Sep 2009
Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos

Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos

00:06:23  |   Wed 02 Sep 2009
Stage IV Pancreatic Islet Cell Tumors: Sunitinib Doubles Progression-Free Survival in Phase III Study

Stage IV Pancreatic Islet Cell Tumors: Sunitinib Doubles Progression-Free Survival in Phase III Study

00:04:37  |   Wed 02 Sep 2009
NCRI Conference, ASCO Annual Meeting, and Perspectives in Lung Cancer European Congress

NCRI Conference, ASCO Annual Meeting, and Perspectives in Lung Cancer European Congress

00:20:17  |   Tue 21 Jul 2009
ASH Annual Meeting

ASH Annual Meeting

00:26:57  |   Tue 21 Jul 2009
More from the ASH Annual Meeting!

More from the ASH Annual Meeting!

00:31:26  |   Tue 21 Jul 2009
10th European Congress on Perspectives in Lung Cancer, Brussels

10th European Congress on Perspectives in Lung Cancer, Brussels

00:07:43  |   Tue 21 Jul 2009
Bilateral Prophylactic Mastectomy for DCIS

Bilateral Prophylactic Mastectomy for DCIS

00:10:46  |   Tue 21 Jul 2009
Cancer-Related Fatigue

Cancer-Related Fatigue

00:12:09  |   Tue 21 Jul 2009
The Smartest Oncologist in the World? – Well, at least in the US!

The Smartest Oncologist in the World? – Well, at least in the US!

00:06:12  |   Tue 21 Jul 2009
Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision

Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision

00:07:15  |   Tue 21 Jul 2009
Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies

Oropharyngeal Cancer: Better Outlook with HPV-Directed Therapies

00:06:40  |   Tue 21 Jul 2009
CML: Hagop Kantarjian on Treating Patients with the T315I Mutation

CML: Hagop Kantarjian on Treating Patients with the T315I Mutation

00:09:09  |   Tue 21 Jul 2009
KRAS-Driven Selection of Molecular Therapy for Metastatic Colorectal Cancer: Choosing Between Bevacizumab, Cetuximab, Panitumomab, or a Combination

KRAS-Driven Selection of Molecular Therapy for Metastatic Colorectal Cancer: Choosing Between Bevacizumab, Cetuximab, Panitumomab, or a Combination

00:03:39  |   Tue 21 Jul 2009
Disclaimer: The podcast and artwork embedded on this page are the property of Oncology Times. This content is not affiliated with or endorsed by eachpod.com.